Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MediciNova asthma drug fails trial; shares crash
Reuters
Wednesday, May 23, 2012 - 7:00pm
tags:
asthma, MedicNova, MN-221
New CEO takes the helm at biotech giant Amgen
Yahoo/AP
Wednesday, May 23, 2012 - 6:59pm
tags:
Amgen, Kevin Sharer, Bob Bradway
FDA panel votes against new use for J&J's Xarelto
Yahoo/AP
Wednesday, May 23, 2012 - 6:58pm
tags:
FDA, advisory panel, Xarelto, bloodthinners, JNJ
Dendreon: Analyst Sees “Epic” Price, Competition Challenges
Barron's
Wednesday, May 23, 2012 - 6:57pm
tags:
Dendreon, prostate cancer, Provenge
Merck CEO assures shareholders there is life after death of Singulair patent
Fierce Pharma
Wednesday, May 23, 2012 - 12:32pm
tags:
Singulair, patents, Merck, Pharma CEOs, Kenneth Frazier, Januvia, Victrelis
Sequenom's Brief, Wondrous Agreement
Motley Fool
Wednesday, May 23, 2012 - 12:20pm
tags:
Sequenom, MaterniT21
Weighing The Benefits Of Osiris' First Cell Therapy Approval
Seeking Alpha
Wednesday, May 23, 2012 - 12:19pm
tags:
stem cells, Osiris, Advanced Cell Technologies, Aastrom Biosciences, NeoStem, JNJ, Dendreon, Prochymal
AVEO Oncology initiates Phase 1 study of AV-203
Yahoo
Wednesday, May 23, 2012 - 12:10pm
tags:
Aveo, AV-203, cancer, monoclonal antibodies
GSK to drop Human Genome bid if "poison pill" stands
Yahoo/Reuters
Wednesday, May 23, 2012 - 12:09pm
tags:
Human Genome Sciences, GSK, M&A, poison pill
Abbott’s New Use for Top Drug Humira Delayed by U.S.
Bloomberg Businessweek
Wednesday, May 23, 2012 - 12:06pm
tags:
Humira, Abbott Laboratories, FDA, ulcerative colitis
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Pharma Times, UK
Wednesday, May 23, 2012 - 12:05pm
tags:
Eli Lilly, dulaglutide, diabetes
2 Drug Combination Stocks Targeting Leukemia
Seeking Alpha
Wednesday, May 23, 2012 - 12:04pm
tags:
leukemia, Threshold Pharmaceuticals, Pharmacyclics, ibrutinib, chronic lymphocytic leukemia, TH-302
NovaBay's Market Cap Doesn't Adequately Value Pipeline Potential
Seeking Alpha
Wednesday, May 23, 2012 - 11:59am
tags:
NovaBay
Novo Nordisk Diabetes Drug Approved For Toddlers
Investors.com
Wednesday, May 23, 2012 - 11:52am
tags:
diabetes, Novo Nordisk, Levemir
Bill introduced to curb practices of "gray marketers" price-gouging on short-supply medicines
Yahoo/AP
Wednesday, May 23, 2012 - 11:50am
tags:
price gouging, gray marketers
Synergy Pharmaceuticals May Be Ready To Roll
Seeking Alpha
Wednesday, May 23, 2012 - 11:49am
tags:
Synergy Pharmaceuticals, plecanatide
Report Card: Johnson & Johnson And Selected Peers
Seeking Alpha
Wednesday, May 23, 2012 - 11:47am
tags:
JNJ, Abbott Laboratories, Bristol-Myers Squibb, Merck, Pfizer, Sanofi
Comparing 2 Dividend Plays In Healthcare
Seeking Alpha
Wednesday, May 23, 2012 - 11:45am
tags:
dividends, Pfizer, JNJ
Novo’s Insulin Pill Quest Is Holy Grail For Diabetics
Bloomberg
Wednesday, May 23, 2012 - 11:45am
tags:
insulin, diabetes, Novo Nordisk
Biotechs raise new VC rounds to back inhalable drugs, antimicrobials
Fierce Biotech
Tuesday, May 22, 2012 - 11:28am
tags:
Zurex Pharma, venture capital, Prosonix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.